Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

November 2022; Volume 42,Issue 11

Reviews

  • Open Access
    Clinical Impact of Nutrition and Inflammation Assessment Tools in Gastric Cancer Treatment
    TORU AOYAMA, KENTARO HARA, KEISUKE KAZAMA and YUKIO MAEZAWA
    Anticancer Research November 2022, 42 (11) 5167-5180; DOI: https://doi.org/10.21873/anticanres.16023
  • Open Access
    Management of Resistant Post-transplant Lymphoproliferative Disorder: CAR-T Is a New Option
    JAN STYCZYNSKI, JAGODA SADLOK, TOMASZ STYCZYNSKI, AGATA MARJANSKA and MONIKA RICHERT-PRZYGONSKA
    Anticancer Research November 2022, 42 (11) 5181-5186; DOI: https://doi.org/10.21873/anticanres.16024

Experimental Studies

  • Open Access
    Suppression of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances the Anti-invasive Efficacy of Selective ERβ Agonists
    VIVIEN SCHMITZ, GERD BAUERSCHMITZ, JULIA GALLWAS and CARSTEN GRÜNDKER
    Anticancer Research November 2022, 42 (11) 5187-5194; DOI: https://doi.org/10.21873/anticanres.16025
  • Open Access
    Candidate Oncogenes, ARHGAP4, NOS3, and OR51B5, for the Development of Scirrhous-type Gastric Cancer
    TOMOHIRO SERA, TAKASHI SAKUMA, KOJI MARUO, GEN TSUJIO, YURIE YAMAMOTO, ATSUSHI SUGIMOTO, SYUHEI KUSHIYAMA, SHINGO TOGANO, KENJI KURODA, HIROAKI KASASHIMA, MASAICHI OHIRA and KIYOSHI MAEDA
    Anticancer Research November 2022, 42 (11) 5195-5203; DOI: https://doi.org/10.21873/anticanres.16026
  • Open Access
    Inhibition of STAT3 Promotes Effector T Cell Infiltration But also Immunosuppression in the HCC Tumor Microenvironment
    TAKETO SASAKI, KOHEI SHIGETA, SHUJI KITAHARA, YASUHIRO SUZUKI, SHIMPEI MATSUI, RYO SEISHIMA, KOJI OKABAYASHI, DAN G. DUDA and YUKO KITAGAWA
    Anticancer Research November 2022, 42 (11) 5205-5215; DOI: https://doi.org/10.21873/anticanres.16027
  • Open Access
    Oral-recombinant Methioninase in Combination With Rapamycin Eradicates Osteosarcoma of the Breast in a Patient-derived Orthotopic Xenograft Mouse Model
    NORIYUKI MASAKI, QINGHONG HAN, CARISSA SAMONTE, NATHANIEL F. WU, CHIHIRO HOZUMI, JUSTIN WU, KOYA OBARA, YUTARO KUBOTA, YUSUKE AOKI, MICHAEL BOUVET and ROBERT M. HOFFMAN
    Anticancer Research November 2022, 42 (11) 5217-5222; DOI: https://doi.org/10.21873/anticanres.16028
  • Open Access
    High Expression of CD58 and ALDH1A3 Predicts a Poor Prognosis in Basal-like Breast Cancer
    YUYUN XIONG, HITOMI MOTOMURA, SHOMA TAMORI, AYAKA OZAKI, CHOTARO ONAGA, YASUSHI HARA, KEIKO SATO, KOUJI TAHATA, YOHSUKE HARADA, KAZUNORI SASAKI, YUN-WEN ZHENG, SHIGEO OHNO and KAZUNORI AKIMOTO
    Anticancer Research November 2022, 42 (11) 5223-5232; DOI: https://doi.org/10.21873/anticanres.16029
  • Open Access
    Development of Novel Small Antitumor Compounds Inhibiting PD-1/PD-L1 Binding
    YASUTO AKIYAMA, TADASHI ASHIZAWA, AKIRA IIZUKA, TAKAYUKI ANDO, YOSHINOBU ISHIKAWA, RYOTA KONDOU, HARUO MIYATA, CHIE MAEDA, AKARI KANEMATSU, TAKASHI SUGINO and KEN YAMAGUCHI
    Anticancer Research November 2022, 42 (11) 5233-5247; DOI: https://doi.org/10.21873/anticanres.16030
  • You have access
    Luminophore Chemistry for Detection of Urinary Bladder Cancer – Comparison to Cytology and Urinary Rapid Tests (BTA stat®, NMP22® BladderChek® and UBC® Rapid Test)
    THORSTEN H. ECKE, MIKOLAJ SCISLOWSKI, NAZIA HASSAN, MARI SAURA, STEFFEN HALLMANN, STEFAN KOCH, SARI VUOLLE, MORTEZA MALAKOUTIKHAH, KARI KOPRA and HARRI HÄRMÄ
    Anticancer Research November 2022, 42 (11) 5249-5256; DOI: https://doi.org/10.21873/anticanres.16031
  • You have access
    Loss of Heterozygosity of BRCA1/2 as a Predictive Marker for Talazoparib Response
    AVITAL GRANIT MIZRAHI, HANEEN HAMAD, AHINOAM GUGENHEIM, BENJAMIN NISMAN, ANNA KUZNETZ, INNA BEN DAVID, YAEL GELFEND, SHERRI COHEN, AVIAD ZICK, KIM SHEVA, HOVAV NECHUSHTAN, TAMAR PERETZ and AMICHAY MEIROVITZ
    Anticancer Research November 2022, 42 (11) 5257-5263; DOI: https://doi.org/10.21873/anticanres.16032
  • You have access
    Pan-Aurora Kinase Inhibitor Danusertib Induces Apoptosis of Epstein–Barr Virus-transformed B-Cells Through Caspase and Endoplasmic Reticulum Stress Signaling
    JIN SOO KIM and DAE YOUNG HUR
    Anticancer Research November 2022, 42 (11) 5265-5274; DOI: https://doi.org/10.21873/anticanres.16033
  • Open Access
    The Contribution of Matrix Metalloproteinase-7 Promoter Genotypes to Hepatocellular Carcinoma Susceptibility
    TE-CHENG YUEH, HAO-YUAN TSAO, WEI-CHING CHIEN, CHIA-WEN TSAI, JEN-SHENG PEI, MING-HSIEN WU, CHOU-PIN CHEN, CHOU-CHEN CHEN, ZHI-HONG WANG, MEI-CHIN MONG, YA-CHEN YANG, YI-CHIH HUNG, DA-TIAN BAU and WEN-SHIN CHANG
    Anticancer Research November 2022, 42 (11) 5275-5282; DOI: https://doi.org/10.21873/anticanres.16034
  • Open Access
    Significant Contribution of Interleukin-18 Genotypes to Childhood Acute Lymphocytic Leukemia Risk in Taiwanese
    CHAO-CHUN CHEN, HUEY-EN TZENG, CHIEN-CHUNG KUO, S. NGERN SAE LIM, PEI-CHEN HSU, YUAN-NIAN HSU, YU-TING CHIN, WEN-SHIN CHANG, CHUNG-HSING WANG, CHIA-WEN TSAI, JEN-SHENG PEI and DA-TIAN BAU
    Anticancer Research November 2022, 42 (11) 5283-5290; DOI: https://doi.org/10.21873/anticanres.16035
  • You have access
    Significance of Chr9p22.1-p21.3 Deletion in Cancer Development: A Pan-cancer In Silico Analysis
    PAOLA G. GONÇALVES, RUI M. REIS and LUCAS T. BIDINOTTO
    Anticancer Research November 2022, 42 (11) 5291-5304; DOI: https://doi.org/10.21873/anticanres.16036
  • You have access
    Impact of Knowledge-based Plan Model Improvement on Plan Complexity and Deliverability in VMAT For Prostate Cancer: A Multi-institutional Study
    MIKOTO TAMURA, YOSHIHIRO UEDA, JUN-ICHI FUKUNAGA, TATSUYA KAMIMA, YUMIKO SHIMIZU, YUTA MURAKI, KAZUKI KUBO, KIYOSHI NAKAMATSU, MAKOTO HOSONO and HAJIME MONZEN
    Anticancer Research November 2022, 42 (11) 5305-5314; DOI: https://doi.org/10.21873/anticanres.16037
  • You have access
    Establishment and Characterisation of Human Clear Cell Sarcoma and Malignant Melanoma Cell Lines
    MASAKO ISHIGURO, TOMOKO FUKUSHIGE, HIROSHI IWASAKI and MAKOTO HAMASAKI
    Anticancer Research November 2022, 42 (11) 5315-5322; DOI: https://doi.org/10.21873/anticanres.16038
  • You have access
    Changes in Serum Trace Element Concentrations Before and After Surgery in Resectable Breast Cancer
    ERIKO TAKAHASHI, KAZUHIRO IMAI, MAYUKO FUKUYAMA, KAORI TERATA, HIROSHI NANJO, KOICHI ISHIYAMA, YUKO HIROSHIMA, MISAKO YATSUYANAGI, CHIAKI KUDO, AOI MORISHITA, AKIYUKI WAKITA, SHINOGU TAKASHIMA, YUSUKE SATO, KYOKO NOMURA and YOSHIHIRO MINAMIYA
    Anticancer Research November 2022, 42 (11) 5323-5334; DOI: https://doi.org/10.21873/anticanres.16039
  • Open Access
    Role of Matrix Metallopeptidase-2 Genotypes in Taiwanese Patients With Colorectal Cancer
    TE-CHENG YUEH, YI-CHIH HUNG, HSU-TUNG LEE, MEI-DUE YANG, ZHI-HONG WANG, YA-CHEN YANG, TAO-WEI KE, JEN-SHENG PEI, CHIA-WEN TSAI, DA-TIAN BAU and WEN-SHIN CHANG
    Anticancer Research November 2022, 42 (11) 5335-5342; DOI: https://doi.org/10.21873/anticanres.16040
  • You have access
    Engulfment and Cell Motility 1 (ELMO1) Regulates Tumor Cell Behavior and Predicts Prognosis in Colorectal Cancer
    YOUNG-LAN PARK, SUNG-BUM CHO, SUN-YOUNG PARK, HYUNG-HOON OH, EUN MYUNG, CHAN-MUK IM, SEYEONG SON, SEUNGHEE KIM, SEO-YEON CHO, MIN-WOO CHUNG, JI-YUN HONG, KI-HYUN KIM, DAE-SEONG MYUNG, WAN-SIK LEE, DAEHO PARK and YOUNG-EUN JOO
    Anticancer Research November 2022, 42 (11) 5343-5355; DOI: https://doi.org/10.21873/anticanres.16058
  • You have access
    Intravascular Administration of Acridine Orange and Zoledronate in a Bone Metastasis Model of Breast Cancer
    RYO SHOJI, HIROYUKI TSUCHIE, HIROYUKI NAGASAWA, MICHIO HONGO, YUJI KASUKAWA, KOJI NOZAKA, DAISUKE KUDO, HIKARU SAITO, KAZUNOBU ABE, SHUN IGARASHI, SHUNTARO HARATA, FUMIHITO KASAMA and NAOHISA MIYAKOSHI
    Anticancer Research November 2022, 42 (11) 5357-5363; DOI: https://doi.org/10.21873/anticanres.16041
  • You have access
    The Activity of Vitamin C Against Ovarian Cancer Cells Is Enhanced by Hyperthermia
    ALICJA BIEŃKOWSKA-TOKARCZYK, ANETA MANDA-HANDZLIK, KRZYSZTOF GAWRYCHOWSKI, URSZULA DEMKOW and MACIEJ MAŁECKI
    Anticancer Research November 2022, 42 (11) 5365-5383; DOI: https://doi.org/10.21873/anticanres.16042
  • You have access
    15-Prostaglandin Dehydrogenase Inhibition Enhances Colon Cancer Metastasis by Up-regulation of Epithelial-to-Mesenchymal Transition Genes
    SUN-HEE KIM, SEONG EUN SONG, HYUNGJOO BAIK, DAE YOUNG HUR, MI SEON KANG and KI BEOM BAE
    Anticancer Research November 2022, 42 (11) 5385-5396; DOI: https://doi.org/10.21873/anticanres.16043
  • You have access
    Effects of Cyclooxygenase-2 in Canine Melanoma-derived Extracellular Vesicles on Tumor Microenvironment In Vitro
    NA-HYEONG KIM, JU-HYUN AN, JEONG-HWA LEE, SU-MIN PARK, KYEONG-BO KIM, TAE-HYUN KIM, YE-IN OH, KYEONG-WON SEO and HWA-YOUNG YOUN
    Anticancer Research November 2022, 42 (11) 5397-5405; DOI: https://doi.org/10.21873/anticanres.16044
  • You have access
    Determination of Clonogenic Radiosensitivity of HeLa Cells in Early and Late G1 Phases
    KOHKI TOHYAMA, ATSUSHI KAIDA and MASAHIKO MIURA
    Anticancer Research November 2022, 42 (11) 5407-5413; DOI: https://doi.org/10.21873/anticanres.16045

Clinical Studies

  • Open Access
    Prognostic Role of Porphyromonas gingivalis Gingipain Rgp and Matrix Metalloproteinase 9 in Oropharyngeal Squamous Cell Carcinoma
    ANNA KAISA KYLMÄ, TIMO SORSA, LAURI JOUHI, HARRI K. MUSTONEN, HESHAM MOHAMED, REIJA RANDÉN-BRADY, ANTTI MÄKITIE, TIMO ATULA, JAANA HAGSTRÖM and CAJ HAGLUND
    Anticancer Research November 2022, 42 (11) 5415-5430; DOI: https://doi.org/10.21873/anticanres.16046
  • Open Access
    Letermovir Prophylaxis for CMV Reactivation in Allogeneic Stem Cell Recipients: A Retrospective Single Center Analysis
    KATRIN KOCH, LENA OSSWALD, ISABELLA MILLER, KRISCHAN BRAITSCH, KATHARINA GÖTZE, FLORIAN BASSERMANN, PETER HERHAUS and MAREIKE VERBEEK
    Anticancer Research November 2022, 42 (11) 5431-5441; DOI: https://doi.org/10.21873/anticanres.16047
  • Open Access
    Vascularized and Non-vascularized Fibula Grafts in Tumour Reconstruction: Single Centre Experience With Mid to Long-term Results
    SABINA M. GORSKI, CHAO DONG, ULRICH LENZE, MARTIN HAUG and ANDREAS. H. KRIEG
    Anticancer Research November 2022, 42 (11) 5443-5447; DOI: https://doi.org/10.21873/anticanres.16048
  • You have access
    Impact of Routine Surveillance Imaging on Recurrence in Sinonasal Malignancies
    KEVIN KING, RYAN RAUCH, SOUMYAJIT ROY, OLEG MENYOK, KEN TATEBE, BOBBY TAJUDEEN, PETER PAPAGIANNOPOULOS, PETE S. BATRA, MIHIR BHAYANI, SAMER AL-KHUDARI, KIRSTEN STENSON, MICHAEL J. JELINEK, MARY JO FIDLER and NIKHIL JOSHI
    Anticancer Research November 2022, 42 (11) 5449-5455; DOI: https://doi.org/10.21873/anticanres.16049
  • Open Access
    Effect of Palliative Care Decision on Use of Hospital Services in Pancreatic Cancer Patients: A Retrospective Study
    SOFIA MIINALAINEN, ANTTI RISSANEN, RIIKKA-LEENA LESKELA, TIINA SAARTO, OUTI HIRVONEN and ANU ANTTONEN
    Anticancer Research November 2022, 42 (11) 5457-5463; DOI: https://doi.org/10.21873/anticanres.16050
  • You have access
    Initial Experience With Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma: A Real-world Retrospective Study
    SOICHI TAKEDA, TADASHI NAMISAKI, YUKI TSUJI, YUKI FUJIMOTO, KOJI MURATA, MASAHIDE ENOMOTO, YUKIHISA FUJINAGA, NORIHISA NISHIMURA, KOH KITAGAWA, HIROAKI TAKAYA, KOSUKE KAJI, TAKASHI INOUE, HIDETO KAWARATANI, TAKEMI AKAHANE, AKIRA MITORO and HITOSHI YOSHIJI
    Anticancer Research November 2022, 42 (11) 5465-5473; DOI: https://doi.org/10.21873/anticanres.16051
  • You have access
    Molecular Characteristics and Immunogenomic Profiling of Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma in a 68-year-old Patient
    GRACE HUANG, LEONARD N. HOWARD, EDGAR ALONSOZANA, DAVID SILL, DEBASHISH BOSE and JINPING LAI
    Anticancer Research November 2022, 42 (11) 5475-5478; DOI: https://doi.org/10.21873/anticanres.16052
  • You have access
    Rechallenge With Lenvatinib After Atezolizumab Plus Bevacizumab Treatment for Hepatocellular Carcinoma
    SHOHEI KOMATSU, YOSHIHIKO YANO, MASAHIRO KIDO, KAORI KURAMITSU, HIDETOSHI GON, KENJI FUKUSHIMA, TAKESHI URADE, SHINICHI SO, ATSUSHI YAMAMOTO, TADAHIRO GOTO, HIROAKI YANAGIMOTO, HIROCHIKA TOYAMA, YOSHIHIDE UEDA, YUZO KODAMA and TAKUMI FUKUMOTO
    Anticancer Research November 2022, 42 (11) 5479-5486; DOI: https://doi.org/10.21873/anticanres.16053
  • Open Access
    PTX Treatment of Colon Cancer: Mode of Action Based on Tumor Marker and Cytokine Kinetics
    AMICHAY MEIROVITZ, LEA BAIDER, TAMAR PERETZ, SAMIR STEPHANOS and VIVIAN BARAK
    Anticancer Research November 2022, 42 (11) 5487-5496; DOI: https://doi.org/10.21873/anticanres.16054
  • You have access
    Efficacy of Adjuvant Chemotherapy Following Curative Resection of Colorectal Cancer Liver Metastases
    KAZUHISA TAKEDA, YUTARO KIKUCHI, YU SAWADA, TAKAFUMI KUMAMOTO, JUN WATANABE, CHIKARA KUNISKI, TOSHIHIRO MISUMI and ITARU ENDO
    Anticancer Research November 2022, 42 (11) 5497-5505; DOI: https://doi.org/10.21873/anticanres.16055
  • You have access
    Surgery, Limb Edema and Health-related Quality of Life: A Prospective Follow-up Study on Patients With Cutaneous Malignant Melanoma
    PIA HEINO, PIA MYLLÄRI, TIINA JAHKOLA, MINNA-LIISA LUOMA, PIRJO RÄSÄNEN and RISTO P. ROINE
    Anticancer Research November 2022, 42 (11) 5507-5519; DOI: https://doi.org/10.21873/anticanres.16056
  • Open Access
    Interleukin-18 (IL-18) Cytokine Serum Concentrations Correlate With Pain Scores and the Number of Analgesic Doses Following Surgery
    MAARET ESKELINEN, IINA SAIMANEN, TUOMAS SELANDER, ANU HOLOPAINEN, SAMULI ASPINEN, ESA HÄMÄLÄINEN and MATTI ESKELINEN
    Anticancer Research November 2022, 42 (11) 5521-5526; DOI: https://doi.org/10.21873/anticanres.16057
  • You have access
    Pre-and Postoperative Circulating Tumour DNA in Patients With Gastrointestinal Stromal Tumour – A Methodological Assessment Study
    CHARLOTTE MARGARETA BRINCH, NINNA AGGERHOLM-PEDERSEN, TIM SVENSTRUP POULSEN, WOJCIECH SKOVRIDER-RUMINSKI, PIETER DE HEER, LUIT PENNINGA, ANDERS KRARUP-HANSEN and ESTRID HOGDALL
    Anticancer Research November 2022, 42 (11) 5527-5537; DOI: https://doi.org/10.21873/anticanres.16022
  • You have access
    Neoadjuvant Therapy for Patients With Non-small Cell Lung Cancer Complicated With Chest Wall Invasion
    KEIYU SATO, SHOTA NAKAMURA, YUKA KADOMATSU, HARUSHI UENO, TAKETO KATO, NAOKI OZEKI, KOICHI FUKUMOTO and TOYOFUMI FENGSHI CHEN-YOSHIKAWA
    Anticancer Research November 2022, 42 (11) 5539-5546; DOI: https://doi.org/10.21873/anticanres.16059
  • You have access
    Association Between a High Gene Expression Variant of Chymase and Increased Risk for Basal Cell Carcinoma
    SEVASTIANA CHARALAMPIDOU, IPHIGENIA GINTONI, DIMITRIS AVGOUSTIDIS, VERONICA PAPAKOSTA, DIMITRIOS VLACHAKIS, STAVROS VASSILIOU and CHRISTOS YAPIJAKIS
    Anticancer Research November 2022, 42 (11) 5547-5552; DOI: https://doi.org/10.21873/anticanres.16060
  • You have access
    Clinical Significance of Early Recurrence After Curative Resection of Colorectal Cancer
    NATSUKO YAMAUCHI, TAKERU MATSUDA, RYUICHIRO SAWAD, HIROSHI HASEGAWA, KIMIHIRO YAMASHITA, HITOSHI HARADA, NAOKI URAKAWA, HIRONOBU GOTO, SHINGO KANAJI, TARO OSHIKIRI and YOSHIHIRO KAKEJI
    Anticancer Research November 2022, 42 (11) 5553-5559; DOI: https://doi.org/10.21873/anticanres.16061
  • Open Access
    Distress Scores During a Course of Radiotherapy: A Pilot Study
    CANSU DELIKANLI, STEFAN JANSSEN, DIRK KEIL, SØREN TVILSTED, STEVEN E. SCHILD and DIRK RADES
    Anticancer Research November 2022, 42 (11) 5561-5566; DOI: https://doi.org/10.21873/anticanres.16062
  • You have access
    Prognostic Significance of the Nodal Ratio and Number of Positive Nodes in Patients With Squamous Cell Carcinomas of the Head and Neck
    ISABELL REUTER, HANS-HELGE MÜLLER and SUSANNE WIEGAND
    Anticancer Research November 2022, 42 (11) 5567-5570; DOI: https://doi.org/10.21873/anticanres.16063
  • You have access
    The Significance of Staging Laparoscopy in Detection of Radiologically Occult Peritoneal Carcinomatosis in Gastric Cancer With Gastric Outlet Obstruction: Consideration of The Optimal Treatment Approach
    MASARU KOMATSU, TAKAHIRO KINOSHITA, EIGO AKIMOTO, MITSUMASA YOSHIDA, DAIKI TERAJIMA, HIROMI NAGATA, TAKUMI HABU, TAKAFUMI OKAYAMA, YUYA TAKABE, JUNICHIRO HARADA, MASAYUKI YAMAGUCHI and MASAHIRO YURA
    Anticancer Research November 2022, 42 (11) 5571-5578; DOI: https://doi.org/10.21873/anticanres.16064
  • You have access
    Hispanic vs. Caucasian Race/Ethnicity in Adrenocortical Carcinoma Patients
    ANDREA PANUNZIO, STEFANO TAPPERO, CRISTINA CANO GARCIA, MATTIA PICCINELLI, FRANCESCO BARLETTA, REHA-BARIS INCESU, ZHE TIAN, ALESSANDRO TAFURI, DERYA TILKI, ALBERTO BRIGANTI, OTTAVIO DE COBELLI, FELIX K.H. CHUN, CARLO TERRONE, FRED SAAD, SHAHROKH F. SHARIAT, ISABELLE BOURDEAU, MARIA ANGELA CERRUTO, ALESSANDRO ANTONELLI and PIERRE I. KARAKIEWICZ
    Anticancer Research November 2022, 42 (11) 5579-5585; DOI: https://doi.org/10.21873/anticanres.16065
  • You have access
    Neoadjuvant Modified Short-course Radiotherapy for Stage IV Rectal Cancer
    HIROSHI DOI, MASAYUKI FUJIWARA, NAOHITO BEPPU, HIROYUKI YOKOYAMA, SHOGO HARUI, AYAKO SUGIHARA, HIDENORI YANAGI, YOSHIO HISHIKAWA, NAOKI YAMANAKA and NORIHIKO KAMIKONYA
    Anticancer Research November 2022, 42 (11) 5587-5595; DOI: https://doi.org/10.21873/anticanres.16066
  • You have access
    Detection of Recurrence After Primary Treatment for Oropharyngeal Carcinoma
    FREDRIK LANDSTRÖM, JOHAN REIZENSTEIN and STEFAN KRISTIANSSON
    Anticancer Research November 2022, 42 (11) 5597-5600; DOI: https://doi.org/10.21873/anticanres.16067
  • You have access
    Clinicopathological Characterization of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
    HA YOUNG WOO, SEOUNG WAN CHAE, SUNG-IM DO and KIYONG NA
    Anticancer Research November 2022, 42 (11) 5601-5608; DOI: https://doi.org/10.21873/anticanres.16068
  • You have access
    Potential Utility of the Mallampati Score for Prediction of Treatment Compliance and Safety Profiles of Patients With Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiotherapy
    PO-HSU SU, CHIH-CHUNG HSU, SHUN-WEN HSUEH, CHIA-YEN HUNG, KUN-YUN YEH, HUNG-MING WANG, CHANG-HSIEN LU, YU-CHING LIN, JOSEPH TUNG-CHIEH CHANG and WEN-CHI CHOU
    Anticancer Research November 2022, 42 (11) 5609-5618; DOI: https://doi.org/10.21873/anticanres.16069
  • You have access
    Thyroglobulin Levels as a Predictor of Papillary Cancer Recurrence After Thyroid Lobectomy
    JIN-SEONG CHO and HEE KYUNG KIM
    Anticancer Research November 2022, 42 (11) 5619-5627; DOI: https://doi.org/10.21873/anticanres.16070
  • Open Access
    A Survival Score for Very Elderly Patients With Brain Metastases Assigned to Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy
    DIRK RADES, CANSU DELIKANLI, OLIVER BLANCK, STEVEN E. SCHILD and STEFAN JANSSEN
    Anticancer Research November 2022, 42 (11) 5629-5634; DOI: https://doi.org/10.21873/anticanres.16071
  • You have access
    The Clinical Impact of Other Primary Cancer in Patients Who Received Curative Treatment for Esophageal Cancer
    TORU AOYAMA, YUKIO MAEZAWA, KENTARO HARA, MIWHA JU, KEISUKE KOMORI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, KEISUKE KAZAMA, SHO SAWAZAKI, ITARU HASHIMOTO, KAZUKI KANO, HARUHIKO CHO, JUNYA MORITA, KENKI SEGAMI, TETSUSHI ISHIGURO, TSUTOMU SATO, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO
    Anticancer Research November 2022, 42 (11) 5635-5641; DOI: https://doi.org/10.21873/anticanres.16072
  • You have access
    Gustave Roussy Immune Score for Predicting Postoperative Complications and Non-cancer Death in Elderly Patients With Colon Cancer
    TETSURO TOMINAGA, TAKASHI NONAKA, SHOSABURO OYAMA, YUMA TAKAMURA, SHINTARO HASHIMOTO, TOSHIO SHIRAISHI, TERUMITSU SAWAI and TAKESHI NAGAYASU
    Anticancer Research November 2022, 42 (11) 5643-5653; DOI: https://doi.org/10.21873/anticanres.16073
  • You have access
    Evaluating Neoadjuvant Chemotherapy for Lower Esophageal Squamous Cell Carcinoma by Measuring Esophageal Wall Thickness
    HIROMICHI SATO, KAZUHIRO NISHIKAWA, TAKUYA HAMAKAWA, CHIKAKO KUSUNOKI, MASAKAZU MIYAKE, ATSUSHI MIYAMOTO, TAKESHI KATO, MASAYUKI MANO, KOJI TAKAMI and MOTOHIRO HIRAO
    Anticancer Research November 2022, 42 (11) 5655-5662; DOI: https://doi.org/10.21873/anticanres.16074
  • You have access
    Vater Papilla-preserving Strategy for Advanced Hepatocellular Carcinoma With Excessive Bile Duct Tumor Thrombus
    KENSUKE YAMAMURA, TORU BEPPU, KEIJIRO INOUE, KAZUKI MATSUMURA, ERI ODA, YASUNORI NAGAYAMA, TOSHIHIKO MOTOHARA, HIDEAKI MIYAMOTO, YOSHIHIRO KOMOHARA, HIROHISA OKABE, TATSUNORI MIYATA and TAKATOSHI ISIKO
    Anticancer Research November 2022, 42 (11) 5663-5670; DOI: https://doi.org/10.21873/anticanres.16075

Corrigenda

  • Open Access
    Corrigenda
    Anticancer Research November 2022, 42 (11) 5671-5672;
Back to top
PreviousNext

In this issue

Anticancer Research: 42 (11)
Anticancer Research
Vol. 42, Issue 11
November 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Inhibition of STAT3 Promotes Effector T Cell Infiltration But also Immunosuppression in the HCC Tumor Microenvironment
  • Suppression of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances the Anti-invasive Efficacy of Selective ERβ Agonists
  • Candidate Oncogenes, ARHGAP4, NOS3, and OR51B5, for the Development of Scirrhous-type Gastric Cancer
  • Prognostic Role of Porphyromonas gingivalis Gingipain Rgp and Matrix Metalloproteinase 9 in Oropharyngeal Squamous Cell Carcinoma
  • Letermovir Prophylaxis for CMV Reactivation in Allogeneic Stem Cell Recipients: A Retrospective Single Center Analysis
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Corrigenda
  • Top Topics
  • Most Cited
  • Most Read
Loading
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire